Get the Stockscreener App
51.29
0.21%
-0.11
Pre-market:
51.46
0.17
+0.33%
Tempus Ai Inc stock is traded at $51.29, with a volume of 6.01M.
It is down -0.21% in the last 24 hours and down -4.22% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$51.40
Open:
$51.89
24h Volume:
6.01M
Relative Volume:
1.21
Market Cap:
$9.17B
Revenue:
$1.27B
Net Income/Loss:
$-245.03M
P/E Ratio:
-36.45
EPS:
-1.4071
Net Cash Flow:
$-245.36M
1W Performance:
-4.51%
1M Performance:
-4.22%
6M Performance:
-34.34%
1Y Performance:
-2.73%
1-Day Range:
$50.32
$52.48
1-Week Range:
$48.75
$55.46
52-Week Range:
$36.22
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
51.29 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
VEEV
Veeva Systems Inc
|
188.48 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
BTSG
Brightspring Health Services Inc
|
41.96 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
81.15 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.93 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
ARK Investment Management LLC Has $579.16 Million Position in Tempus AI, Inc. $TEM - MarketBeat
Is Tempus AI, Inc. (TEM) A Good Stock To Buy Now? - Insider Monkey
Director David R. Epstein sells Tempus AI (TEM) shares under 10b5-1 plan - Stock Titan
Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era - The Cancer Letter
Tempus’ growth can’t shake Wall Street’s worries - Crain's Chicago Business
What Does the Market Think About Tempus AI Inc? - Benzinga
Tempus AI expands collaboration with Merck on precision medicine By Investing.com - Investing.com Australia
AI-Powered Tempus Inks New Multi-Year Merck Deal - Bitget
Top Artificial Intelligence Stocks To Add to Your WatchlistMarch 3rd - MarketBeat
Tempus AI (NASDAQ:TEM) Price Target Lowered to $70.00 at Morgan Stanley - MarketBeat
Merck’s Oncology Results And Tempus AI Deal Reframe Post Keytruda Future - simplywall.st
Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes - Benzinga
Merck (MRK) Partners with Tempus AI for Precision Oncology Advan - GuruFocus
Merck to collaborate with Tempus AI on precision oncology - Seeking Alpha
Tempus AI, Inc. Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine - marketscreener.com
Tempus announces strategic collaboration agreement with Merck to accelerate AI-driven precision medicine - marketscreener.com
Tempus AI, Merck Collaborate on AI-Driven Precision Medicine - marketscreener.com
Tempus AI expands collaboration with Merck on precision medicine - Investing.com India
Tempus Announces Strategic Collaboration Agreement With Merck To Accelerate Ai-Driven Precision Medicine - TradingView
Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine - The Joplin Globe
Tempus AI, Inc. $TEM Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
34,648 Shares in Tempus AI, Inc. $TEM Acquired by Intech Investment Management LLC - MarketBeat
Tempus AI (TEM) Is Down 6.9% After Raising 2026 Outlook And Filing ESOP Shelf Offering - simplywall.st
Quantbot Technologies LP Buys Shares of 50,089 Tempus AI, Inc. $TEM - MarketBeat
TEM (NASDAQ: TEM) insider sale files 870 restricted units - Stock Titan
Tempus AI, Inc. (NASDAQ:TEM) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound - MarketBeat
Best Artificial Intelligence Stocks To ResearchFebruary 27th - MarketBeat
Tempus AI Expands Oncology Portfolio With HRD-RNA And Lung Screening Deal - simplywall.st
Dakota Wealth Management Has $1.06 Million Stock Holdings in Tempus AI, Inc. $TEM - MarketBeat
Why Tempus AI (TEM) Is Down 7.5% After 2025 Results, 2026 Outlook And ESOP Shelf RegistrationAnd What's Next - Yahoo Finance
How The Tempus AI (TEM) Investment Story Is Evolving With New Data And Valuation Views - Yahoo Finance
Top Artificial Intelligence Stocks To Keep An Eye OnFebruary 26th - MarketBeat
Is It Time To Reassess Tempus AI (TEM) After Recent Share Price Weakness? - Yahoo Finance
Tempus AI: Buy The Post-Earnings Dip (NASDAQ:TEM) - Seeking Alpha
Tempus AI CEO Eric Lefkofsky set for fireside chat at Morgan Stanley TMT event - Stock Titan
Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), BridgeBio Pharma (BBIO) and Establishment Labs Holdings (ESTA) - The Globe and Mail
Cathie Wood Is Buying The Tempus AI Dip, Ark Snaps Up Stock Worth $11 MillionTempus AI (NASDAQ:TEM) - Benzinga
Tempus AI (TEM) Loss Deepens To US$0.30 EPS As Premium Valuation Thesis Faces Test - simplywall.st
Cathie Wood’s ARK sells PagerDuty stock, buys Tempus AI By Investing.com - Investing.com India
Cathie Wood’s ARK sells PagerDuty stock, buys Tempus AI - Investing.com
[Form 3] Tempus AI, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Tempus AI sold off after a beat but the rebound case is building - MSN
Tempus AI Sold Off After a Beat—But the Rebound Case Is Building - MarketBeat
Tempus AI: No AI Interruption Detected (NASDAQ:TEM) - Seeking Alpha
Promising Artificial Intelligence Stocks To Follow NowFebruary 25th - MarketBeat
Tempus AI (TEM) Stock: Insider Selling Tops $37M as JPMorgan Cuts Price Target - CoinCentral
JPMorgan Chase & Co. Issues Pessimistic Forecast for Tempus AI (NASDAQ:TEM) Stock Price - MarketBeat
Tempus AI (NASDAQ:TEM) Price Target Cut to $75.00 by Analysts at Needham & Company LLC - MarketBeat
Tempus AI (NASDAQ:TEM) Trading Down 7.4% After Analyst Downgrade - MarketBeat
Stifel cuts Tempus AI stock price target to $60 on valuation - Investing.com
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.22%
1.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):